AU · rank #20 · 2026-10-20
OR
PARIS · EUR · $241.07B (USD)
The exact numbers the algorithm saw.
| Composite score Z-score blend of all factors below. | 0.024 |
|---|---|
| EPS revisions (30d) Change in consensus EPS estimate over the past 30 days ($/share). | +$0.03 |
| Net revisions (30d) Number of analysts revising upward minus downward. | 6 |
| Insider signal (90d) | — |
| Analyst upside Consensus target $418.00 | +3.6% |
| Momentum acceleration 3-month minus 12-month momentum. | +5.01% |
| Analyst rating 5 = Strong Buy, 1 = Strong Sell. | 4.00 |
| Gross margin TTM | +74.4% |
| 52w high | $407.40 |
| Market cap (USD) | $241.07B |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
L'Oréal is the world's largest beauty company, operating across Consumer Products, Luxe, Dermatological Beauty and Professional Products with €23.77 billion in first-half 2026 sales and a record 21.3% operating margin.
Rationale
The analyst_upside_pct of 3.57% is modest but supported by 20 analysts, 75% revision agreement, net positive 30-day EPS revisions, and 5% momentum acceleration, suggesting a broad, conviction-backed re-rating rather than a thin outlier call.
Material risks
- 1Target price dispersion of 28.7% is unusually wide for a mega-cap defensive, signalling genuine analyst disagreement on China recovery trajectory and margin durability that could cap the re-rating if H2 2026 data disappoints on October 22.
- 2China's mass-market segment remains slightly negative even as premium recovers, and local/regional brands continue taking share, meaning the China outperformance story is category-narrow and fragile rather than broad-based.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 3 of 3 voted to proceed.